Srivats Srinivasan1,2, Laura L Lehman1, Julie Swanson1, Darren B Orbach1, and Jeffrey N Stout1
1Cerebrovascular Surgery and Interventions Center, Boston Children's Hospital, Boston, MA, United States, 2University of Texas Southwestern Medical Center, Dallas, TX, United States
Synopsis
Keywords: Blood vessels, Pediatric, Cerebrovascular, reactivity, CVR, moyamoya
We compared the reliability of BOLD CVR (cerebrovascular reactivity)
between two regression approaches – etpCO
2 signal and average
cerebellar signal – in pediatric moyamoya patients. We estimated CVR using a
lagged optimized GLM model, conducted cortical parcellation, and compared
left-right hemispheric CVR differences to clinical and imaging reports. We
found that etpCO
2 had poorer fits during regression compared to the
cerebellar approach (p<0.0001) and incorrectly identified disease laterality
in 2/8 patients. These effects were strongly observed in subjects with poor
breath-hold task compliance, indicating that the cerebellar approach is
more reliable for studies of young pediatric moyamoya patients.
Introduction
Clinical management of
children with moyamoya disease may be improved by the development of robust and
reliable hemodynamic metrics of brain health. One such metric is
cerebrovascular reactivity (CVR), which is the ability for brain vasculature to
increase blood flow in response to vasodilatory stimuli.1 In
blood-oxygen level dependent (BOLD) CVR, there are many methods both to evoke
vasodilatation as well as to analyze the hemodynamic change.2,3
Breath-hold induced CVR is one such method, and when analyzed with a general
linear model regressor of the average cerebellar signal, it has been shown to
provide clinical utility as a predictor for ischemic stroke in pediatric
moyamoya.4,5
However, task compliance and
breath-hold tolerance vary greatly in young pediatric patients. and previous
studies of reliability of CVR are often limited to healthy subjects.1,6
Our objective was to compare the reliability of detecting breath-hold BOLD-CVR
changes in cases of pediatric moyamoya disease using two different regressors
in the analysis: the average cerebellar BOLD signal, and end-tidal pCO2
(etpCO2). We hypothesized that, in the setting of sufficiently compliant
breath-hold task performance, etpCO2-based CVR would more reliably correlate
with presenting clinical symptoms and angiographic findings.Methods
Subjects underwent an MRI before
undergoing revascularization surgery as part of an IRB approved study. The MRI
protocol included T1-weighted anatomical imaging (TR=2500ms, TE=1.69-7.27ms,
FOV=256x256mm2 , resolution=1mm isotropic) and CVR mapping via
breath-hold BOLD imaging (TR=1150ms, TE=30ms, FOV=234x234mm2,
resolution=3mm isotropic, SMS=3) with continuous acquisition during a
breath-hold challenge consisting of five 20s breath holds with post-hold
exhalation and self-paced recovery breathing.4 Induced hypercapnia
was monitored using a capnometer sampling through a nasal cannula with mouth
scoop.
BOLD data was pre-processed
using fMRIPREP 20.2.6.7 Parameter maps of CVR (%BOLD/mmHg for etpCO2
CVR and Δ%BOLD/BOLD for cerebellar CVR) were calculated using a lagged optimized
regression approach.8 CVR values for maps were considered
significant based on the critical T-statistic >1.96 (p<0.05), similar to
previous approaches.9 Parcellations from the FreeSurfer analysis in
fMRIPREP were used for comparison between the two analyses.10
Interhemispheric differences in CVR were determined by conducting T-tests
between left and right groups of whole brain and the cerebral cortex voxels.
These comparisons were cross-referenced to disease laterality described in each
subject’s angiography and neurology reports.Results
For the 11 pediatric moyamoya
patients (7 female, mean age: 13.4 yrs, ranging 10-20 yrs) the mean gray matter
CVR across subjects with the etpCO2
analysis is 0.087 %BOLD/mmHg (SD: 0.10) and the cerebellar analysis is 0.13
%BOLD/BOLD (SD: 0.16). During calculation of parameter maps, for all patients,
the etpCO2 analysis had more voxels that did not meet the threshold for
significance compared to the cerebellar approach (p<0.0001), with a mean of
3% more of each parcellated brain region being removed. Example parameter maps
are shown in Figure 1.
Left-right hemispheric
differences in CVR were found in 8/11 patients in both end-tidal and cerebellar
approaches (p<0.0001, Bonferroni corrected). The cerebellar analysis found
corresponding laterality to angiography and clinical history in 8/8 patients,
but the end-tidal approach was only consistent for 6/8 patients (see Table 1).
Correlating mean CVR values for each cortical parcel between both analyses
found significant positive linear associations in only 5/11 patients (p<0.0001,
Bonferroni corrected) (see Figure 3).Discussion
We explored two analysis approaches
for breath-hold CVR in a cohort of
children with moyamoya disease. Lower mean t-statistic (GLM fit) by cortical
parcel (Figure 2) and fewer voxels retained for significance in the etpCO2
approach implies worse fits for regression compared to the cerebellar approach.
Worse correspondence between clinical reports and etpCO2-CVR also suggests
reduced potential clinical utility.
Overall agreement between the
two approaches is only good in some cases (see Figure 3). Subjects
without good correlation between the approaches appeared to have poorer breath
hold performance (see Figure 4). Subjects in our study were less consistent in
their breath holds compared to previous studies of breath-hold performance in
adults.11,12,9 Overall our findings suggest that the etpCO2 analysis approach may not be
appropriate for breath-hold CVR in
pediatric moyamoya disease. Defining a metric of breath hold compliance would
be the next step in exploring the difference between analysis approaches. Future
work should pinpoint the threshold at which the etpCO2 approach to CVR analysis
deteriorates for subjects who do not consistently obey breathing cues.Conclusion
Using etpCO2 for CVR analysis led
to poorer consistency between CVR findings and disease symptoms. This is because
subjects were unable to perform the task with high fidelity, and therefore this
study supports previous cerebellar CVR approaches to pediatric moyamoya for
effective clinical utilization.3Acknowledgements
The Thrasher Research Fund provided funds supporting this work. Special thanks to Stefano Moia at EPFL for his advice in using his CVR analysis tool, phys2cvr.References
1.
Bright,
Molly G., and Kevin Murphy. 2013. “Reliable Quantification of BOLD fMRI
Cerebrovascular Reactivity despite Poor Breath-Hold Performance.” NeuroImage
83 (December): 559.
2.
Dlamini,
N., P. Shah-Basak, J. Leung, F. Kirkham, M. Shroff, A. Kassner, A. Robertson,
et al. 2018. “Breath-Hold Blood Oxygen Level-Dependent MRI: A Tool for the
Assessment of Cerebrovascular Reserve in Children with Moyamoya Disease.” AJNR.
American Journal of Neuroradiology 39 (9): 1717–23.
3.
Dlamini,
N., M. Slim, F. Kirkham, M. Shroff, P. Dirks, M. Moharir, D. MacGregor, A.
Robertson, G. deVeber, and W. Logan. 2020. “Predicting Ischemic Risk Using
Blood Oxygen Level-Dependent MRI in Children with Moyamoya.” AJNR. American
Journal of Neuroradiology 41 (1): 160–66.
4.
Esteban,
Oscar, Christopher J. Markiewicz, Ross W. Blair, Craig A. Moodie, A. Ilkay
Isik, Asier Erramuzpe, James D. Kent, et al. 2019. “fMRIPrep: A Robust
Preprocessing Pipeline for Functional MRI.” Nature Methods 16 (1):
111–16.
5.
Fierstra,
J., O. Sobczyk, A. Battisti-Charbonney, D. M. Mandell, J. Poublanc, A. P.
Crawley, D. J. Mikulis, J. Duffin, and J. A. Fisher. 2013. “Measuring
Cerebrovascular Reactivity: What Stimulus to Use?” The Journal of Physiology
591 (23): 5809–21.
6.
Koep,
Jodie L., Alan R. Barker, Rhys Banks, Rohit R. Banger, Kate M. Sansum, Max E.
Weston, and Bert Bond. 2020. “The Reliability of a Breath-Hold Protocol to
Determine Cerebrovascular Reactivity in Adolescents.” Journal of Clinical
Ultrasound: JCU 48 (9): 544–52.
7.
Fisher,
Joseph A., Lashmi Venkatraghavan, and David J. Mikulis. 2018. “Magnetic
Resonance Imaging-Based Cerebrovascular Reactivity and Hemodynamic Reserve.” Stroke;
a Journal of Cerebral Circulation 49 (8): 2011–18.
8.
Moia,
Stefano, Rachael C. Stickland, Apoorva Ayyagari, Maite Termenon, Cesar
Caballero-Gaudes, and Molly G. Bright. 2020. “Voxelwise Optimization of
Hemodynamic Lags to Improve Regional CVR Estimates in Breath-Hold fMRI.” Conference
Proceedings: Annual International Conference of the IEEE Engineering in
Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society.
Conference 2020 (July): 1489–92.
9.
Stickland,
Rachael C., Kristina M. Zvolanek, Stefano Moia, Apoorva Ayyagari, César
Caballero-Gaudes, and Molly G. Bright. 2021. “A Practical Modification to a
Resting State fMRI Protocol for Improved Characterization of Cerebrovascular
Function.” NeuroImage 239 (October): 118306.
10. Reuter, M.,
Schmansky, N.J., Rosas, H.D., Fischl, B. 2012. Within-Subject Template
Estimation for Unbiased Longitudinal Image Analysis. Neuroimage 61 (4),
1402-1418.
11. Pinto, Joana, Molly G. Bright, Daniel P.
Bulte, and Patrícia Figueiredo. 2020. “Cerebrovascular Reactivity Mapping
Without Gas Challenges: A Methodological Guide.” Frontiers in Physiology
11: 608475.
12.
Zvolanek,
Kristina M., Rachael C. Stickland, Molly G. Bright. 2020. “Feasibility of a
cued deep breathing task to map cerebrovascular reactivity in healthy and
clinical pediatric cohorts”. Conference Proceedings: ISMRM & SMRT
Conference 2020. International Society for Magnetic Resonance in Medicine.
2020 (August): 4603.